AKEBIA THERAPEUTICS INC. - COMMON STOCK

Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa

03 أبريل 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 أبريل 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025

25 مارس 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Announces Pricing of Public Offering of Common Stock

19 مارس 2025 22:17:53 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Announces Proposed Public Offering of Common Stock

19 مارس 2025 16:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

19 مارس 2025 10:01:40 بحسب NetDania Notify

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

18 مارس 2025 13:14:28 بحسب NetDania Notify

Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update

13 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights

06 مارس 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 فبراير 2025 16:05:00 بحسب Nasdaq GlobeNewswire